IL147254A0 - Vitamin d3 analogs - Google Patents

Vitamin d3 analogs

Info

Publication number
IL147254A0
IL147254A0 IL14725400A IL14725400A IL147254A0 IL 147254 A0 IL147254 A0 IL 147254A0 IL 14725400 A IL14725400 A IL 14725400A IL 14725400 A IL14725400 A IL 14725400A IL 147254 A0 IL147254 A0 IL 147254A0
Authority
IL
Israel
Prior art keywords
analogs
vitamin
Prior art date
Application number
IL14725400A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL147254A0 publication Critical patent/IL147254A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14725400A 1999-07-12 2000-07-06 Vitamin d3 analogs IL147254A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12
PCT/EP2000/006393 WO2001004089A1 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs

Publications (1)

Publication Number Publication Date
IL147254A0 true IL147254A0 (en) 2002-08-14

Family

ID=22503954

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14725400A IL147254A0 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs
IL147254A IL147254A (en) 1999-07-12 2001-12-23 Analogs of Vitamin D3

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147254A IL147254A (en) 1999-07-12 2001-12-23 Analogs of Vitamin D3

Country Status (36)

Country Link
US (1) US6331642B1 (ar)
EP (1) EP1200399B1 (ar)
JP (1) JP3803579B2 (ar)
KR (1) KR100477161B1 (ar)
CN (1) CN1174964C (ar)
AR (1) AR024695A1 (ar)
AT (1) ATE262508T1 (ar)
AU (1) AU779408B2 (ar)
BR (1) BR0012419A (ar)
CA (1) CA2378803C (ar)
CO (1) CO5190683A1 (ar)
DE (1) DE60009303T2 (ar)
DK (1) DK1200399T3 (ar)
EG (1) EG23909A (ar)
ES (1) ES2215707T3 (ar)
GC (1) GC0000198A (ar)
HK (1) HK1047578B (ar)
HR (1) HRP20020007A2 (ar)
HU (1) HUP0202157A3 (ar)
IL (2) IL147254A0 (ar)
JO (1) JO2255B1 (ar)
MA (1) MA26808A1 (ar)
MX (1) MXPA02000313A (ar)
MY (1) MY122633A (ar)
NO (1) NO20020161L (ar)
NZ (1) NZ516339A (ar)
PE (1) PE20010328A1 (ar)
PL (1) PL201877B1 (ar)
PT (1) PT1200399E (ar)
RS (1) RS50229B (ar)
RU (1) RU2235721C2 (ar)
TR (1) TR200200054T2 (ar)
TW (1) TWI268276B (ar)
UY (1) UY26239A1 (ar)
WO (1) WO2001004089A1 (ar)
ZA (1) ZA200110487B (ar)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
US6777441B2 (en) 2000-10-02 2004-08-17 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
KR100628586B1 (ko) * 2001-09-21 2006-09-26 에프. 호프만-라 로슈 아게 3-데속시-비타민 디3 유사 에스테르
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
AU2004235775A1 (en) * 2003-04-30 2004-11-18 Bioxell S.P.A. Gemini vitamin D3 compounds and methods of use thereof
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
US20070054887A1 (en) * 2003-09-24 2007-03-08 Bioxell S.P.A Methods for treating bladder dysfunction
SG110107A1 (en) * 2003-09-24 2005-04-28 Bioxell Spa Compound and use in treatment
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
EP1797033A4 (en) * 2004-09-24 2010-04-28 Bioxell Spa 20-CYCLOALKYL-26,27-ALKYL / HALOGENALKYL-VITAMIN-D3 COMPOUNDS AND METHODS FOR THEIR APPLICATION
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
JP5480131B2 (ja) * 2007-05-30 2014-04-23 シトクロマ インコーポレイテッド ホスフィンオキシドビタミンｄ前駆物質の製造方法
KR102057826B1 (ko) 2008-04-11 2019-12-20 추가이 세이야쿠 가부시키가이샤 복수 분자의 항원에 반복 결합하는 항원 결합 분자
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
NO20020161D0 (no) 2002-01-11
TWI268276B (en) 2006-12-11
NO20020161L (no) 2002-01-11
TR200200054T2 (tr) 2002-06-21
PE20010328A1 (es) 2001-03-22
ATE262508T1 (de) 2004-04-15
EG23909A (en) 2007-12-30
RS50229B (sr) 2009-07-15
PL201877B1 (pl) 2009-05-29
WO2001004089A1 (en) 2001-01-18
AU6689400A (en) 2001-01-30
UY26239A1 (es) 2000-10-31
MA26808A1 (fr) 2004-12-20
CO5190683A1 (es) 2002-08-29
AU779408B2 (en) 2005-01-20
IL147254A (en) 2006-07-05
CA2378803C (en) 2009-01-27
BR0012419A (pt) 2002-03-26
KR20020033728A (ko) 2002-05-07
DE60009303T2 (de) 2005-02-24
KR100477161B1 (ko) 2005-03-18
ZA200110487B (en) 2003-03-20
EP1200399A1 (en) 2002-05-02
NZ516339A (en) 2003-07-25
US6331642B1 (en) 2001-12-18
MXPA02000313A (es) 2002-06-21
JP2003504354A (ja) 2003-02-04
DE60009303D1 (de) 2004-04-29
HUP0202157A2 (en) 2002-10-28
YU92701A (sh) 2004-09-03
HRP20020007A2 (en) 2003-04-30
GC0000198A (en) 2006-03-29
EP1200399B1 (en) 2004-03-24
CN1174964C (zh) 2004-11-10
MY122633A (en) 2006-04-29
AR024695A1 (es) 2002-10-23
DK1200399T3 (da) 2004-07-19
RU2235721C2 (ru) 2004-09-10
HK1047578B (zh) 2005-04-29
HUP0202157A3 (en) 2004-04-28
CN1360572A (zh) 2002-07-24
HK1047578A1 (en) 2003-02-28
ES2215707T3 (es) 2004-10-16
PT1200399E (pt) 2004-06-30
PL356124A1 (en) 2004-06-14
CA2378803A1 (en) 2001-01-18
JP3803579B2 (ja) 2006-08-02
JO2255B1 (ar) 2004-10-07

Similar Documents

Publication Publication Date Title
PL347548A1 (en) Vitamin d analogues
AU7895601A (en) Stabilized 1alpha-hydroxy vitamin d
GB2357761B (en) Compounds
GB9914222D0 (en) Pharmeceutical compounds
TW587632U (en) Elevator
AU140483S (en) Outsole
SG70009A1 (en) Vitamin d3 analogs
GC0000198A (en) Vitamin d3 analogs
PL344686A1 (en) Vitamin b12
AU2002360487A8 (en) Acyclovir-peptide analogs
GB9906457D0 (en) Anti-oxidant
PL355432A1 (en) Vitamin d analogues
SI1456160T1 (sl) Analogi vitamina D
ZA9811460B (en) Novel vitamin d3 derivatives
GB9901902D0 (en) Manipulating isoprenoid expression
IL146184A0 (en) Antioxidative vitamin b6 analogs
AU6550800A (en) Hepoxilin analogs
GB9905498D0 (en) Expression
SI1200399T1 (en) Vitamin d3 analogs
PL356301A1 (en) Novel vitamin d analogues
GB9916950D0 (en) Walkway
AU2337801A (en) Angiopoietin analogs
TW520740U (en) Escalator
AU2291600A (en) New vitamin d analogs
GB9924096D0 (en) Supplement

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed